다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Eledon Pharmaceuticals Inc (ELDN)
Eledon Pharmaceuticals Inc (ELDN) 뉴스

ELDN

Eledon Pharmaceuticals (ELDN)

Eledon Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ELDN

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/25	05:02	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/15	20:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/14	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/09	20:30	GlobeNewswire Inc.	Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/09	20:00	GlobeNewswire Inc.	Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/07	20:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/07	20:05	GlobeNewswire Inc.	Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/07	20:00	GlobeNewswire Inc.	Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/03/29	05:01	GlobeNewswire Inc.	Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/03/26	05:56	GlobeNewswire Inc.	Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/03/21	23:31	GlobeNewswire Inc.	Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/02/15	05:35	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/02/15	05:01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/02/14	09:01	GlobeNewswire Inc.	Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/01/05	06:40	GlobeNewswire Inc.	Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/12/05	08:00	GlobeNewswire Inc.	Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/30	06:05	GlobeNewswire Inc.	Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/10	07:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/10	06:01	GlobeNewswire Inc.	Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/09	06:05	GlobeNewswire Inc.	Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/03	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/02	22:05	GlobeNewswire Inc.	Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/10/23	20:00	GlobeNewswire Inc.	Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/10/13	20:00	GlobeNewswire Inc.	Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/10/04	05:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/10/04	05:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/10/03	06:51	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/10/03	06:08	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/10/02	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/10/02	20:00	GlobeNewswire Inc.	Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors	NASDAQ:ELDN	Eledon Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:ELDN

1 2 3 4 5 6 다음 >>

Invesco QQQ Trust Series 1

BNP Paribas (QX)

US Dollar vs Sterling

Verizon Communications

JP Morgan Chase

Energy Select Sector SPDR

Gold vs US Dollar

Bank of America

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관